LUNGEVITY FOUNDATION
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.lungevity.org/
Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
Recruiting
- Conditions
- Lung Cancer PatientsCaregivers
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- LUNGevity Foundation
- Target Recruit Count
- 1300
- Registration Number
- NCT05826756
- Locations
- 🇺🇸
LUNGevity Foundation, Bethesda, Maryland, United States
News
Less Restrictive Trial Criteria May Improve Outcomes in Metastatic NSCLC
A retrospective study suggests that less restrictive eligibility criteria in clinical trials for metastatic non-small cell lung cancer (NSCLC) could improve patient outcomes.
FDA and LUNGevity Collaborate to Standardize Lung Cancer Trial Eligibility
LUNGevity, FDA, and NCI are collaborating to standardize eligibility criteria for advanced non-small cell lung cancer (NSCLC) clinical trials, aiming to simplify trial navigation for patients.